当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:104.03亿  总市值:104.03亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润3.81亿元,每股收益1.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益461813.60万元,未分配利润206017.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产578746.88万元,负债116933.28万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入2,283,832,911.431,782,020,224.831,223,284,970.75686,909,061.52
营业总成本1,941,857,521.471,468,536,204.53979,179,228.79538,737,974.7
营业利润401,827,808.74340,804,804.26256,790,390.69154,276,662.98
利润总额401,956,704.73342,418,496.53258,868,887.07154,701,391.69
净利润381,008,045.8318,977,945.89239,137,127.93141,852,238.97
其他综合收益-13,065,819.88-23,664,262.3-24,452,127.4212,754.54
综合收益总额367,942,225.92295,313,683.59214,685,000.51141,864,993.51
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计2,652,447,941.352,660,812,428.82,405,604,989.662,748,960,813.13
非流动资产合计3,135,020,853.662,980,882,308.023,181,116,685.132,937,874,816.02
资产总计5,787,468,795.015,641,694,736.825,586,721,674.795,686,835,629.15
流动负债合计1,022,403,542.51948,841,682.54936,632,024.16987,889,894.8
非流动负债合计146,929,219.71151,377,325.7152,522,625.35142,448,597.74
负债合计1,169,332,762.221,100,219,008.241,089,154,649.511,130,338,492.54
归属于母公司股东权益合计4,371,550,511.014,301,632,773.154,254,327,364.484,342,842,117.06
股东权益合计4,618,136,032.794,541,475,728.584,497,567,025.284,556,497,136.61
负债和股东权益合计5,787,468,795.015,641,694,736.825,586,721,674.795,686,835,629.15
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计2,429,286,249.011,654,629,831.451,088,512,990.31560,317,919.65
经营活动现金流出小计2,137,619,330.751,540,662,380.111,029,236,956.55483,112,922.83
经营活动产生的现金流量净额291,666,918.26113,967,451.3459,276,033.7677,204,996.82
投资活动现金流入小计2,981,647,918.692,056,540,467.271,296,735,713.19384,384,067.11
投资活动现金流出小计3,772,864,625.612,511,099,207.531,294,636,967.71391,913,472.06
投资活动产生的现金流量净额-791,216,706.92-454,558,740.262,098,745.48-7,529,404.95
筹资活动现金流入小计193,985,922.810,550,00010,250,0005,170,000
筹资活动现金流出小计420,813,197.24230,530,706.38202,206,159.4325,666,108.43
筹资活动产生的现金流量净额-226,827,274.44-219,980,706.38-191,956,159.43-20,496,108.43
汇率变动对现金及现金等价物的影响4,434,529.58962,777.382,036,804.431,245,666.7
现金及现金等价物净增加额-721,942,533.52-559,609,217.92-128,544,575.7650,425,150.14
期末现金及现金等价物余额534,704,030.68697,037,346.281,128,101,988.441,307,071,714.34
最新报告期:2025-04-15
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信证券宋硕,陈竹,曾令鹏1.381.651.962025-04-15
华创证券郑辰,李婵娟1.391.712.022025-04-09
东海证券伍可心,杜永宏1.281.521.772025-04-08
国盛证券杨芳,张金洋1.411.682.042025-04-07
华西证券王睿,崔文亮1.401.742.082025-04-02
TOP↑